Several different serologic centered assays have been described, and while the majority detect anti-StrongyloidesIgG, they differ in the antigen targets utilized for detection (crude lysate versus purified or recombinant proteins), in the applied methodology (enzyme-linked immunosorbent assays [ELISAs], dipstick methods, or luciferase immunoprecipitation systems [LIPS]), and whether the assay is definitely commercially available or laboratory-developed test (4,1519). of samples regarded as positive or bad by a single method were related. Compared to the consensus result, the overall percent agreement of the InBios, SciMedx, and LIPS assays were similar at 87.1%, 84.2%, and 89.1%, respectively. Finally, the two ELISAs performed analogously but shown only moderate agreement (kappa coefficient for the two assays, 0.53) with the LIPS assay. Collectively, while the two commercially available ELISAs perform equivalently, neither should be used individually of medical evaluation to diagnose strongyloidiasis. == Intro == Strongyloides stercoralis, a soil-transmitted intestinal nematode and the causative agent of strongyloidiasis, is definitely widely endemic in both tropical and subtropical climates throughout Africa, Asia, and South NPS-2143 (SB-262470) America (1). Extension into temperate areas has also been reported, including pouches of endemicity in the southeastern United States (2,3). Given its wide geographical distribution,S. stercoralishas been estimated to infect as many as 100 million people worldwide and is therefore an important illness to consider in individuals who either reside in or have traveled to areas that are endemic for strongyloidiasis (4,5). S. stercoralishas a complicated life cycle, and infection can be asymptomatic, present with gastrointestinal symptoms, or in more severe cases, progress to disseminated disease. Briefly, the NPS-2143 (SB-262470) skin is definitely penetrated by infectiveS. stercoralisL3 filariform larvae via direct exposure to contaminated soil. Initial illness can lead to pruritus and irritation at the site of access (larva currens), typically along the lower extremities (6). Subsequent hematogenous dissemination to the lungs, migration up the bronchial tree, and passage into the gastrointestinal tract may present clinically as respiratory symptoms, diarrhea, and/or abdominal pain (6,7).S. stercoralisis unique among the intestinal nematodes because of its ability to adult into the infective filariform stage without leaving the gastrointestinal tract. This creates the potential for continuous reinfection and hyperinfection syndrome, a potentially life-threatening condition, particularly among immunosuppressed individuals (710). As many instances of strongyloidiasis are subclinical and may persist for decades following exposure, a significant number of individuals with undiagnosed strongyloidiasis are at risk for hyperinfection once initiated on immunosuppressive regimens (6,11). Consequently, accurate diagnostic modalities are needed for both the analysis of symptomatic strongyloidiasis and the recognition of asymptomatic infections in high-risk individuals prior to receiving immunosuppressants. Diagnosing strongyloidiasis is particularly demanding. Unlike most other intestinal helminths,S. stercoralisdoes not produce characteristic ova within the intestinal tract, and therefore, direct observation of the larva is required. Classic techniques to identifyStrongyloidesinclude larval concentration from fecal specimens prior to microscopic exam, NPS-2143 (SB-262470) and agar plate culture of new stool specimens along with daily plate inspections for the presence of bacterial trails remaining by TEF2 motileS. stercoralislarva. However, due to sporadic larval dropping and generally low larval concentrations, particularly among chronically infected individuals, the diagnostic sensitivities of these direct detection methods from solitary stool specimens are low (30 to 50%), and repeat sampling (up to seven specimens) may be necessary prior to ruling out illness (1214). Additionally, these methods require prompt submission of fresh stool specimens to the laboratory, which may be impractical in some cases, and asS. stercoralisis infective on contact, the manipulation of this nematode poses a significant illness risk to laboratory personnel. Given the limitations of these traditional techniques, serologic approaches to detect an immune response toS. stercoralishave emerged as valuable alternate diagnostic tools. Several different serologic centered assays have been described, and while the majority detect anti-StrongyloidesIgG, they differ in the antigen focuses on utilized for detection (crude lysate versus purified or recombinant proteins), in the applied strategy (enzyme-linked immunosorbent assays [ELISAs], dipstick methods, or luciferase immunoprecipitation systems [LIPS]), NPS-2143 (SB-262470) and whether the assay is definitely commercially available or laboratory-developed test (4,1519). In instances of verified strongyloidiasis, the sensitivities of these serologic assays vary from 73% to 100%, with false negatives mentioned in immunosuppressed individuals. Specificity is definitely similarly inconsistent (29% to 100%) between methods, with cross-reactions happening primarily in individuals with previous filarial infections (17,18,20,21). Among these assays, the National Institutes of Health (NIH) LIPS method presents the highest combined level of sensitivity and specificity (97% and 100%, respectively) for the detection of anti-S. stercoralisantibodies (16,17,19). The purpose of this study was to evaluate the performance of the recently released InBios Strongy Detect IgG ELISA (InBios International, Inc., Seattle, WA) compared to those of both the commercially available SciMedxStrongyloidesserology microwell.